Skip to content

Effect of Diclofenac Sodium Versus Calcium Hydroxide as Intracanal Medication on the Intensity of Postoperative Pain, Bacterial Load Reduction and MMP-9 Levels in Patients With Necrotic Pulp.

Effect of Diclofenac Sodium Versus Calcium Hydroxide as Intracanal Medication on the Intensity of Postoperative Pain, Bacterial Load Reduction and MMP-9 Levels in Patients With Necrotic Pulp: A Randomized Clinical Trial

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05582421
Enrollment
30
Registered
2022-10-17
Start date
2022-12-31
Completion date
2024-08-31
Last updated
2022-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apical Periodontitis, Necrotic Pulp

Keywords

necrosis

Brief summary

the aim of this study is to compare the effect of using Diclofenac Sodium Versus Calcium Hydroxide as Intracanal medication on intensity of postoperative pain, bacterial load reduction after root canal preparation and periapical matrix metalloproteinase 9 level (MMP-9) post-instrumentation and pre-obturation in teeth with necrotic pulp

Detailed description

To compare the effect of diclofenac sodium versus calcium hydroxide as intra canal medication on: \- Primary Outcome Intensity of postoperative pain will be measured using numerical rating scale (NRS) at 6, 12, 24 and 48- hours post-instrumentation and at 6, 12, 24 and 48 hours post-obturation. Secondary Outcome 1 Bacterial load reduction will be determined by bacterial counting using agar culture technique after root canal preparation (CFU/ml). Secondary Outcome 2 Periapical MMP-9 level will be determined post-instrumentation and pre-obturation by ELISA.

Interventions

DRUGDiclofenac Sodium

intracanal medication

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

* In this proposed study, both the participant and assessor will be blinded. This is achieved where the outcome assessor will not be informed of the group in which the participant is enrolled for subjective outcomes. The participants will be blinded to the study hypothesis as to which intervention is expected to be better. * The patients who already do not know their treatment group will assess the level of their post-operative pain. * The laboratory technician at the microbiological department will not know the treatment group of the patients. * The treatment groups will remain anonymous at the end of the study during assessment by the statistician.

Intervention model description

Trial Design: Randomized Clinical Trial (Parallel Group) Two Arms Allocation Ratio: 1:1 Framework: Superiority

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

\- Inclusion criteria: * Patients who are free from any physical or mental handicapping condition with no underlying systemic disease. * Age between 18-50 years. * Males & Females. * Mandibular single rooted permanent premolar teeth: * Diagnosed clinically with pulp necrosis. * Absence of spontaneous pain. * Positive pain on percussion denoting apical periodontitis. * Slight widening in the periodontal membrane space or with periapical radiolucency not exceeding 2\*2 mm radiographically. * Patients' acceptance to participate in the trial. * Patients who can understand pain scale and can sign the informed consent

Exclusion criteria

* Medically compromised patients * Pregnant women. * If analgesics or antibiotics have been administrated by the patient during the past 24 hours preoperatively. * Patients reporting bruxism or clenching. * Teeth that show association with acute periapical abscess and swelling. * Greater than grade I mobility or pocket depth greater than 5mm. * Non-restorable teeth * Teeth with vital pulp. * Immature teeth. * Radiographic evidence of external or internal root resorption vertical root fracture, perforation, calcification.

Design outcomes

Primary

MeasureTime frameDescription
change in Intensity of postoperative pain6,12.24.48 hoursmeasured using numerical rating scale (NRS) at 6, 12, 24 and 48- hours post-instrumentation and at 6, 12, 24 and 48 hours post-obturation.

Secondary

MeasureTime frameDescription
Bacterial load reduction7 daysbacterial counting using agar culture technique after root canal preparation (CFU/ml).

Other

MeasureTime frameDescription
Periapical MMP-9 level7 daysdetermined post-instrumentation and pre-obturation by ELISA.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026